Alcobra Ltd. ( ADHD ) saw a big move last session, as the company's shares fell by nearly 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for ADHD, as the stock is now down almost 11% in the past one-month time frame.
The biopharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
ADHD currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the Medical Drugs industry may consider better-ranked stocks like Ariad Pharmaceuticals Inc. ( ARIA ), Grifols, S.A. ( GRFS ) and IGI, Laboratories, Inc. ( IG ). All these stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportALCOBRA LTD (ADHD): Get Free ReportARIAD PHARMA (ARIA): Free Stock Analysis ReportGRIFOLS SA-ADR (GRFS): Free Stock Analysis ReportIGI LABORATORYS (IG): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research